Hi Codered,
I merged your discussion with this existing discussion about EVUSHELD as mentioned by Dr. Poland in this podcast https://connect.mayoclinic.org/blog/podcasts/newsfeed-post/experts-urge-covid-19-boosters-to-fight-omicron-surge/

As @mpeters mentioned you can find more information on the manufacturer's website - AstraZeneca

- EVUSHELD long-acting antibody combination retains neutralizing activity against Omicron variant in independent FDA study https://www.astrazeneca-us.com/media/press-releases/2021/evusheld-long-acting-antibody-combination-retains-neutralizing-activity-against-omicron-variant-in-independent-fda-study.html

"This drug is intended to help people who have received organ or other transplants, and those have cancer or take immune-suppressing drugs for conditions such as rheumatoid arthritis. These conditions prevent COVID vaccines from being fully effective. The new antibody drug will also benefit people who have allergic reactions to vaccines.

The FDA emphasized that Evusheld is not a substitute for a COVID vaccination in people for whom the vaccine is recommended."

Read more here: https://www.webmd.com/lung/news/20211209/antibody-drug-authorized-for-compromised-immune-systems